Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05248581 · ClinicalTrials.gov registry record
Living Donor Liver Transplant for Unresectable Colorectal Liver Metastases
A clinical trial of Colorectal Cancer Metastatic, sponsored by University of Rochester.
- Recruiting
- Registry status
- 25
- Enrollment target
- 1
- Study location
NCT05248581 is a study of Colorectal Cancer Metastatic that is actively recruiting participants, run by University of Rochester. The registered enrollment target is 25 participants, below the 204-participant average among 18 other Colorectal Cancer Metastatic trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05248581, a study of Colorectal Cancer Metastatic, is actively recruiting participants, sponsored by University of Rochester.
- RECRUITING
- Registry status
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to create a data registry to capture clinical, pathologic, and molecular data/outcomes for patients with metastatic colorectal cancer who undergo live donor liver transplantation.
Conditions Studied
Interventions
- PROCEDURE Liver transplantation
Study Locations (1)
New York
- University of Rochester Medical Center - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2019-08-16 |
| Est. Completion | 2027-08-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05248581
The ClinicalTrials.gov registry entry for NCT05248581 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 204-participant average among 18 other Colorectal Cancer Metastatic trials with a reported enrollment target (88% lower). The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Colorectal Cancer Metastatic appearing as the primary indexed condition, and to 1 intervention - of which Liver transplantation is the first listed.
NCT05248581 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05248581 about?
NCT05248581 is a clinical study titled "Living Donor Liver Transplant for Unresectable Colorectal Liver Metastases". The goal of this study is to create a data registry to capture clinical, pathologic, and molecular data/outcomes for patients with metastatic colorectal cancer who undergo live donor liver transplantation.
What is the current status of trial NCT05248581?
This trial is currently recruiting. The enrollment target is 25 participants. The study started on 2019-08-16. Estimated completion is 2027-08-01.
What conditions does trial NCT05248581 study?
This clinical trial studies the following conditions: Colorectal Cancer Metastatic.
What interventions are being tested in trial NCT05248581?
The interventions under investigation include: Liver transplantation (PROCEDURE).
Who is sponsoring clinical trial NCT05248581?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05248581 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer Metastatic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)
RECRUITING · Phase 2
-
Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Metastasis
RECRUITING · Early Phase 1
-
Colorectal Metastasis to Liver Extraction With Auxiliary Transplant and Delayed Resection
RECRUITING
-
INFINITIVE: ImmuNotherapy For PatIeNts wIth colorecTal LIVer MEtastases
RECRUITING · Early Phase 1
-
Medical Cannabis in Patients With Advanced Pancreatic and Colorectal Cancer
RECRUITING · Phase 2
-
Pilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.